https://www.actaitalica.it/issue/feed ACTA Otorhinolaryngologica Italica 2024-04-23T08:53:58+00:00 Cesare Piazza cesare.piazza@unibs.it Open Journal Systems <h1 style="text-align: center;">NEWS!</h1> <h1 style="text-align: center;"><img src="/public/site/images/vbarberi/B_800x200_copia.png" /></h1> <h3 style="text-align: center;"><strong>************************************************************</strong></h3> <h3 style="text-align: center;"> </h3> <h3 style="text-align: center;"> </h3> <p> </p> <h3 style="text-align: center;"><a href="https://www.actaitalica.it/section/view/covid-19-section">Check the latest updates on COVID-19 <br />published in Acta Otorhinolaryngologica Italica</a></h3> <p> </p> <p> </p> https://www.actaitalica.it/article/view/2745 A systematic review of randomised controlled trials on topical nasal steroids 2024-04-23T08:53:51+00:00 Chiara Zeroli chiara.zeroli@gmail.com Armela Gorica armelagorica@gmail.com Giulia Monti giuliamonti2403@gmail.com Paolo Giocondo Maria Castelnuovo paolo.castelnuovo@me.com Maurizio Bignami maurizio.bignami@uninsubria.it Alberto Macchi macchi.doc@gmail.com <p><strong>Introduction</strong>. Intranasal corticosteroids (INCs) are the first line of therapy for chronic sinonasal conditions such as rhinitis and rhinosinusitis. Among these, one of the most frequently used is beclomethasone dipropionate (BDP). Over the years many studies have evaluated the efficacy of BDP as part of therapy for chronic rhinosinusitis (CRS) and allergic rhinitis (AR) along with nasal washes, which seems to be very well tolerated. Objective. To analyse the data in the literature regarding the various therapeutic regimens of BDP in different sinonasal disease and their efficacy and tolerability. <br><strong>Materials and methods</strong>. Using different search engines, the posology, efficacy, and tolerability of BDP were reviewed and a total of 64 full-length articles were examined for eligibility. After applying inclusion and exclusion criteria, 4 articles were reviewed. <br><strong>Results</strong>. BDP is among the group of INCs with significant improvement of nasal symptoms and has good efficacy and safety. <br><strong>Conclusions</strong>. BDP nasal spray is one of the most frequently prescribed INC for rhinitis and rhinosinusitis. Treatment with BDP resulted in significant and clinically meaningful improvements in nasal symptoms associated with AR and CRS. BDP is well tolerated, and the safety profile is similar to that of placebo in most patients. These results, in conjunction with the significant benefit reported in subjects with CRS and AR, provide convincing evidence of the overall effectiveness of BDP for the treatment of the full spectrum of sinonasal disease.</p> 2024-04-22T09:54:54+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2761 Microsurgery in carotid body paraganglioma 2024-04-23T08:53:52+00:00 Antonio Mazzoni antonio.mazzoni02@gmail.com Leonardo Franz leonardo.franz@unipd.it Elisabetta Zanoletti elisabetta.zanoletti@unipd.it <p><strong>Objectives</strong>. In carotid paraganglioma surgery, magnification is crucial to properly evaluate the anatomical relationships between mass, carotid wall, cranial nerves, tumour vascular supply and fascial envelope. The aims of this study are to describe the microsurgical technique, along with the underlying microsurgical anatomy, and to assess outcomes in terms of disease control, complications and functional results. <br><strong>Methods</strong>. Twenty-six patients, accounting for 29 carotid paragangliomas, treated with microsurgery by the same senior surgeon over a 35-year period, were included. <br><strong>Results</strong>. No carotid injury requiring repair, nor peri- or post-operative stroke occurred in this series. No surgical injury of the main trunk of VII to XII cranial nerves occurred. Complete excision was obtained in all cases and no recurrence was observed during follow-up. <br><strong>Conclusions</strong>. The small study size and its retrospective nature suggests caution; however, our results show that microsurgery can allow a safe and precise dissection of the carotids and nerves.</p> 2024-04-22T10:01:06+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2522 Global research on sinonasal inverted papilloma over the past two decades: a bibliometric analysis 2024-04-23T08:53:52+00:00 Dachuan Fan entfdc@163.com Yongjun Zhu zhuyongjun80@163.com Jianming Yang jmyang88@163.com Jinxiao Hou houjinxiao88@163.com <p><strong>Objective</strong>.&nbsp;This study aimed to investigate the global research status, hot topics, and prospects in the field of sinonasal inverted papilloma (SNIP) through bibliometric analysis.<br><strong>Methods</strong>. The literature on SNIP was retrieved and downloaded from the Web of Science Core Collection from 2002 to 2021. The bibliometric and visualisation networks of SNIP were constructed using VOSviewer 1.6.18, CiteSpace 6.1. R2, and a bibliometric online analysis platform.<br><strong>Results</strong>. A total of 560 original articles about SNIP research were included, involving 2,457 authors from 610 institutions in 45 countries. The number of SNIP publications showed an overall rising trend, with an average annual output of 28 articles and almost 3 times as many articles published in 2020 as in 2002. The analysis of keyword burst detection indicated that EGFR mutation, malignant transformation and infection are emerging research hotspots. Moreover, EGFR mutation, KRAS mutation, malignant tumour, metallothionein 2a gene, pre-operative diagnosis, HPV-negative tumour, and expression were among the 11 key clusters of co-cited references.<br><strong>Conclusions</strong>. This study provided a comprehensive, systematic, and objective analysis and visualised knowledge map of SNIP over the past 2 decades. In particular, current hotspots and prospective trends in the field of SNIP have been identified. These results highlight the future direction of SNIP research for rhinologists.</p> 2023-12-29T00:00:00+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2648 Retrospective comparison of first-line treatments for odontogenic sinusitis based on duration of symptoms 2024-04-23T08:53:53+00:00 Kyung Won Kwon dkdla7@naver.com Jang Wook Gwak runsa1013@gmail.com Yoo-Sam Chung entysc@gmail.com <p><strong>Objectives</strong>. To investigate the clinical efficacy of dental treatment and endoscopic sinus surgery (ESS), each primary/combined treatment modality, in patients with odontogenic sinusitis (ODS), according to its phase, acute or chronic. <br><strong>Materials and methods</strong>. We retrospectively reviewed clinical data on 172 patients diagnosed with ODS. They were divided into two groups: acute (≤ 3 months; 90 patients) and chronic (&gt; 3 months; 82 patients) ODS. The success rate and time to resolution of each primary/combined treatment modality were compared between the two groups. <br><strong>Results</strong>. In both ODS groups, the success rate was highest with combined ESS and dental therapy, followed by ESS alone and dental therapy alone. ESS outperformed dental therapy (96.6% <em>vs</em> 65.5% for acute ODS, p = 0.011; 80.6% <em>vs</em> 56.5% for chronic ODS, p = 0.046) and led to quicker resolution of symptoms for acute ODS than dental therapy (0.9 <em>vs</em> 1.7 months, p = 0.012). In the comparison between ESS alone and combined therapy, no significant difference was observed for acute ODS, whereas combined therapy demonstrated a superior success rate for chronic ODS (100% <em>vs</em> 80.6%, p = 0.046). <br><strong>Conclusions</strong>. In our study, the clinical utility of dental treatment and/or ESS depended on the morbidity period of ODS. For chronic ODS, combined ESS and dental treatment seems to be an effective first-line treatment.</p> 2024-02-29T00:00:00+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2634 Nasal nitric oxide measurement in allergic rhinitis and non-allergic rhinitis: a meta-analysis 2024-04-23T08:53:54+00:00 Ahmad Faiz Dahlan zul66067117@gmail.com Md Asiful Islam m.a.islam@bham.ac.uk Norasnieda Md Shukri asnieda@usm.my Baharudin Abdullah profbaha@gmail.com <p>The goal of this meta-analysis was to study nasal nitric oxide (nNO) measurements in allergic rhinitis (AR) and non-allergic rhinitis (non-AR). The protocol was registered with PROSPERO (no: CRD4202124828). Electronic databases from PubMed, Google Scholar, Scopus, Web of Science, and Cochrane were all thoroughly searched and studies were chosen based on the qualifying requirements. The quality of the studies was evaluated by Joanna Briggs Institute evaluation tools, and publication bias using funnel plots. The metaanalysis included 18 studies, whereas the systematic review included 20 studies, totaling 3097 participants (1581 AR, 458 non-AR, and 1058 healthy/control). Patients with AR had significantly greater nNO levels than the control group, although this did not change significantly before or after treatment. AR patients had significantly greater nNO levels than non-AR patients, but there was no significant difference between non-AR patients and healthy controls. Nineteen of the studies were of high quality and the remaining one was of moderate quality. nNO measurement has a promising role in the management of AR and non-AR patients, but more investigations are needed to document clinical benefits.</p> 2024-04-22T10:11:47+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2752 Binaural hearing in monaural conductive or mixed hearing loss fitted with unilateral Bonebridge 2024-04-23T08:53:54+00:00 Andrea Canale andrea.canale@unito.it Anastasia Urbanelli anastasia.urbanelli@unito.it Roberto Albera roberto.albera@unito.it Maria Gragnano mariagragnano91@gmail.com Valerio Bordino valerio.bordino@unito.it Giuseppe Riva giuseppe.riva@unito.it Eugenio Sportoletti Baduel eugenio.sportolettibaduel@unito.it Andrea Albera a.albera@unito.it <p style="font-weight: 400;"><strong>Objective</strong>. To determine the benefits of binaural hearing rehabilitation in patients with monaural conductive or mixed hearing loss treated with a unilateral bone conduction implant (BCI). <br><strong>Methods</strong>. This monocentric study includes 7 patients with monaural conductive or mixed hearing loss who underwent surgical implantation of a unilateral BCI (Bonebridge, Med- El). An ITA Matrix test was performed by each patient included in the study - without and with the BCI and in three different settings – to determine the summation effect, squelch effect and head shadow effect. Subjective hearing benefits were assessed using the Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire. <br><strong>Results</strong>. The difference in signal to noise ratio of patients without and with BCI was 0.79 dB in the summation setting (p &lt; 0.05), 4.62 dB in the head shadow setting (p &lt; 0.05) and 1.53 dB (p = 0.063) in the squelch setting. The APHAB questionnaire revealed a subjective discomfort in the presence of unexpected sounds in patients using a unilateral BCI (aversiveness score) compared to the same environmental situations without BCI, with a mean discomfort score of 69.00% (SD ± 21.24%) with monaural BCI versus 25.67% (SD ± 16.70%) without BCI (difference: -43.33%, p &lt; 0.05). In terms of global score, patients wearing a unilateral Bonebridge implant did not show any significant differences compared to those without hearing aid (difference: -4.00%, p = 0.310).<br><strong>Conclusions</strong>. Our study shows that the use of a unilateral BCI in patients affected by monaural conductive or mixed hearing loss can improve speech perception under noise conditions due to the summation effect and to the decrease of the head shadow effect. However, since monaural BCIs might lead to discomfort under noise conditions in some subjects, a pre-operative assessment of the possible individual benefit of a monaural BCI should be carried out in patients affected by unilateral conductive or mixed hearing loss in order to investigate the possible additional effect of the fitting of hearing aids.</p> 2024-04-22T10:18:47+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2389 Effect of stapes demineralisation on the development of cochlear otosclerosis 2024-04-23T08:53:55+00:00 Maciej Wiatr maciej.wiatr@uj.edu.pl Robert Bartoszewicz rbartoszewicz@wum.edu.pl Kazimierz Niemczyk kazimierz.niemczyk@wum.edu.pl Agnieszka Wiatr agnieszka.wiatr@uj.edu.pl <p><strong>Objective</strong>. The involvement of the inner ear in otosclerosis may lead to the development of cochlear otosclerosis. The aim of this study was to analyse changes in the chemical composition and microstructure of the stapes in the course of otosclerosis compared to healthy stapes. <br><strong>Materials and methods</strong>. This analysis included 31 patients with otosclerosis and 9 patients without otosclerosis. Microanalytical and diffraction techniques were used to assess the elemental distribution and orientation topography of the stapes. <br><strong>Results</strong>. The concentration of Ca2+ in the study group was significantly lower in the area of the anterior crus of the stapes than in the posterior crus. A reduction in the Ca2+/P3+ ratio in the anterior crus was associated with deteriorated bone conduction and tinnitus. Degradation of the stapes microstructure in the area of otosclerotic lesions was observed with scanning electron microscopy. <br><strong>Conclusions</strong>. Bone remodelling is most significant at the closest location to typical otosclerotic lesions with hydroxyapatite porosity and scale-like bone formation according to scanning electron microscopy. There is a relationship between the disturbance of calcium metabolism and the development of clinical symptoms of cochlear otosclerosis.</p> 2024-02-29T00:00:00+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2375 Surgical management of advanced sinonasal cancer: a 10-year mono-institutional experience 2024-04-23T08:53:56+00:00 Giorgio Sileo sileo.giorgio@gmail.com Alberto Daniele Arosio albertodaniele.arosio@gmail.com Alessia Lambertoni alessia.lambertoni@gmail.com Paolo Battaglia mail.paolobattaglia@gmail.com Maurizio Bignami bignami67@me.com Mario Cherubino mario.cherubino@gmail.com Luigi Valdatta luigi.valdatta@uninsubria.it Paolo Antognoni Paolo.Antognoni@ospedale.varese.it Davide Locatelli davide1.locatelli@uninsubria.it Paolo Castelnuovo paolo.castelnuovo@uninsubria.it Mario Turri-Zanoni tzmario@inwind.it <p><strong>Objective</strong>. Endoscopic endonasal surgery is effective in the treatment of sinonasal cancers. However, in cases of well-differentiated locally advanced neoplasms as well as recurrences, the most appropriate treatment is debated. The purpose of this study is to report a monoinstitutional experience on craniofacial surgery performed in a tertiary-care referral centre. <br><strong>Methods</strong>. This was a retrospective analysis of 90 patients treated with transcranial and/ or transfacial resection for sinonasal cancer between 2010 and 2020. Outcome measures included overall survival (OS), disease-specific survival (DSS), disease-free survival (DFS) and recurrence-free survival (RFS). <br><strong>Results</strong>. The 5-year OS, DSS and DFS were 48.2%, 60.6% and 28.7%, respectively. Factors correlated with prognosis were pT-classification (p = 0.002), histotype (p = 0.012) and dural involvement (p = 0.004). Independent prognostic factors were orbital apex infiltration (p = 0.03), age (p = 0.002) and adjuvant therapy (p = 0.03). <br><strong>Conclusions</strong>. When endoscopic endonasal surgery is contraindicated and chemoradiotherapy is not appropriate, craniofacial and transfacial approaches still represent an option to consider, despite the non-negligible morbidity.</p> 2024-04-22T10:31:50+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2638 Comment to the article “Mandibular reconstruction using a new design for a patient-specific plate to support a fibular free flap and avoid the double-barrel technique” by Tarsitano et al., 2021 2024-04-23T08:53:57+00:00 James Pallot james.pallot@wales.nhs.uk Alex Goodson alexander.goodson01@gmail.com Peter Evans PeterLlewelynEvans@wales.nhs.uk Madhav Kittur madhav.kittur@wales.nhs.uk 2024-02-29T00:00:00+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale https://www.actaitalica.it/article/view/2727 Opportunities and obstacles of electronic health records in Italy: towards enhanced surgical care 2024-04-23T08:53:57+00:00 Michaele Francesco Corbisiero michaelefrancesco.corbisiero@cuanschutz.edu Davide Rizzo drizzo@uniss.it Roberto Gallus roberto.gallus@materolbia.com Pierpaolo Loreti pierpaolo.loreti@gmail.com Lorenzo Bracciale lorenzo.bracciale@uniroma2.it Francesco Bussu fbussu@uniss.it 2024-04-22T10:40:17+00:00 Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale